---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-038547"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2023-10-27T23:59:59+00:00"
generated_at: "2026-06-09T07:18:16.566211+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics CAO/Interim CFO Tony Kalajian resigns

## Summary
- Tony Kalajian resigned all positions on October 23, 2023.
- He served as Chief Accounting Officer and interim Chief Financial Officer.
- No replacement or interim successor has been announced.
- No reason for resignation was disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-23-038547
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2023-10-27T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315223038547/0001493152-23-038547-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315223038547/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-038547
- JSON: https://secwatch.observer/filing/0001493152-23-038547.json
- Plain text: https://secwatch.observer/filing/0001493152-23-038547.txt

## Key facts
- Executive change
  Tony Kalajian resigned as Chief Accounting Officer and interim Chief Financial Officer at Calidi Biotherapeutics, Inc..
  - Action: resigned
  - Role: Chief Accounting Officer and interim Chief Financial Officer
  source text: On October 23, 2023, Mr. Tony Kalajian resigned from all positions in Calidi Biotherapeutics, Inc., including his roles as Chief Accounting Officer and as interim Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1855485/000149315223038547/0001493152-23-038547-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.